Free Trial
NASDAQ:COO

Cooper Companies (COO) Stock Price, News & Analysis

$92.46
-1.01 (-1.08%)
(As of 06/17/2024 ET)
Today's Range
$91.76
$93.03
50-Day Range
$88.84
$98.92
52-Week Range
$75.93
$104.07
Volume
789,353 shs
Average Volume
1.09 million shs
Market Capitalization
$18.41 billion
P/E Ratio
54.31
Dividend Yield
N/A
Price Target
$111.42

Cooper Companies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.73 Rating Score
Upside/​Downside
20.5% Upside
$111.42 Price Target
Short Interest
Healthy
1.30% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.20mentions of Cooper Companies in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$5.52 M Sold Last Quarter
Proj. Earnings Growth
10.64%
From $3.57 to $3.95 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.76 out of 5 stars

Medical Sector

443rd out of 913 stocks

Ophthalmic Goods Industry

4th out of 7 stocks

COO stock logo

About Cooper Companies Stock (NASDAQ:COO)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO Stock Price History

COO Stock News Headlines

Biofuel groups envision ethanol-powered jets. But fueling the effort has not been easy
Farming and biofuels organizations are hopeful that ethanol could be used to power passenger jets, but making that dream a reality hasn’t been easy
Inside NBC's Olympics bet on pop culture in Paris, with help from Snoop Dogg and Cardi B
NBC has partnered with several entertainers and non-Olympic athletes like Megan Thee Stallion, Dolly Parton and Peyton Manning to promote the Paris Games this summer
China hosts Arab leaders at summit focused on trade and the Israel-Hamas war
Chinese President Xi Jinping called for an international peace conference focused on the Israel-Hamas war and promised more humanitarian aid as he opened a summit with Arab leaders
Assessing Cooper Companies: Insights From 7 Financial Analysts
Cooper’s Hawk to close in Fort Lauderdale
See More Headlines
Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/30/2024
Today
6/18/2024
Next Earnings (Estimated)
9/04/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:COO
CUSIP
21664840
Employees
15,000
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$111.42
High Stock Price Target
$125.00
Low Stock Price Target
$88.75
Potential Upside/Downside
+20.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

Net Income
$294.20 million
Pretax Margin
12.73%

Debt

Sales & Book Value

Annual Sales
$3.73 billion
Cash Flow
$5.02 per share
Book Value
$38.12 per share

Miscellaneous

Free Float
195,138,000
Market Cap
$18.41 billion
Optionable
Optionable
Beta
1.02

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

COO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cooper Companies stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" COO shares.
View COO analyst ratings
or view top-rated stocks.

What is Cooper Companies' stock price target for 2024?

11 Wall Street analysts have issued 1 year price objectives for Cooper Companies' stock. Their COO share price targets range from $88.75 to $125.00. On average, they predict the company's share price to reach $111.42 in the next twelve months. This suggests a possible upside of 20.5% from the stock's current price.
View analysts price targets for COO
or view top-rated stocks among Wall Street analysts.

How have COO shares performed in 2024?

Cooper Companies' stock was trading at $94.61 at the beginning of the year. Since then, COO stock has decreased by 2.3% and is now trading at $92.46.
View the best growth stocks for 2024 here
.

When is Cooper Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 4th 2024.
View our COO earnings forecast
.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NASDAQ:COO) issued its earnings results on Thursday, May, 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. The medical device company earned $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. Cooper Companies had a trailing twelve-month return on equity of 8.87% and a net margin of 9.11%. Cooper Companies's revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.77 earnings per share.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies declared a quarterly dividend on Wednesday, July 12th. Stockholders of record on Thursday, July 27th will be paid a dividend of $0.0075 per share on Friday, August 11th. This represents a $0.03 dividend on an annualized basis and a yield of 0.03%. The ex-dividend date of this dividend is Wednesday, July 26th.
Read our dividend analysis for COO
.

When did Cooper Companies' stock split?

Shares of Cooper Companies split on the morning of Tuesday, February 20th 2024. The 4-1 split was announced on Tuesday, February 20th 2024. The newly created shares were payable to shareholders after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies issued an update on its FY 2024 earnings guidance on Thursday, May, 30th. The company provided EPS guidance of 3.540-3.600 for the period, compared to the consensus EPS estimate of 3.540. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.62%), Capital World Investors (2.84%), Janus Henderson Group PLC (1.73%), Bessemer Group Inc. (1.01%), Champlain Investment Partners LLC (0.88%) and Bank of New York Mellon Corp (0.87%). Insiders that own company stock include Agostino Ricupati, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Gerard H Warner III, Jody S Lindell and Robert S Weiss.
View institutional ownership trends
.

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cooper Companies have any subsidiaries?
The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.
Read More
This page (NASDAQ:COO) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners